News for hackers. Stuff that matters.
Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by kunai on Friday November 13, 2026 @09:57AM (#50484481)
One of the greatest issues with the tech culture broadly (and it's been festering for some time) is the belief, almost sacrosanct, that the epistemological set of knowledge that technologists and computer scientists have is able to be extrapolated broadly to every profession and field and that hard issues in a field like biology are obviously solved because OpenAI brute forced a few mathematical proofs. It doesn't work like that. Much of this comment reads like a sci-fi wet dream divorced from reality entirely.

The architecture of ML as it currently stands does assist us in modeling things like protein folding. But that's what they are; models. And before some person chimes in by saying "look how the AI pessimists move the goalposts", see my first point. Biological systems have high entropy and discoveries in biology often do not follow from preexisting discoveries whatsoever and are completely novel. Barring some quantum leap in ML design and architecture you cannot predict stochastically or deterministically how exactly a new enzyme will function in vivo. There is absolutely no evidence that Anthropic has solved this, even if they gobbled up every ML tool used in drug design and trained their models on every biomolecule known to man, it would not work because of fundamental gaps in what can be observed. They are a for-profit company trying to juice their IPO.

Now could LLMs and ML potentially speed up the pace of this research? Absolutely. But it's like saying a Formula 1 car is faster than a NASCAR. Yes, one is very clearly faster, but it's not as if the NASCARs are slow.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @10:02AM (#50484571)
Amodei has a PHD in biophysics and he researched cancer biomarkers at Stanford; it's not like he doesn't know what he's talking about.

You can make the argument that Amodei is dishonest or that he suffers from psychosis.

However, he has made no claims that Anthropic has solved this, and expressing a hope to solve this in the next 5-10 years is hardly fraudulent.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by disgruntledphd2 on Friday November 13, 2026 @10:30AM (#50484986)
> Amodei has a PHD in biophysics and he researched cancer biomarkers at Stanford; it's not like he doesn't know what he's talking about.

That's why I think that something is very weird with his statements. Like, how would this even work?

The feedback loop is much, much, much too slow right now for AI to make things better.

Like, step 1 is build a digital model of the human organism. If you can do this, then yeah maybe the rest is possible. But step 1 is incredibly hard, so it feels unlikely.

That being said, I think the stimulants hypothesis upthread may be correct, as I've heard a lot of crazy stuff from friends on them.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @10:47AM (#50485231)
Of course Opus 5.5 is not going to help build a digital model of the human organism.

If we linearly interpret the last year of progress from GPT-5 to Opus 5.5, times 5x, assuming no plateau, could such an intelligence realistically achieve a task like that?

Maybe also not, perhaps some form of RSI would need to deliver accelerating progress.

There are a lot of assumptions and speculation here. Still, at the end of the day, it does not seem that unlikely that they succeed in creating AI that can reason over so many parameters as to remove all intellectual bottlenecks from the process, leaving mainly the physical limitations.

And what is the limit there to building a good model of the human organism? I won't pretend that I know, but simply pointing to clinical trials, as some here do, instead of making an argument based on how such a digital model cannot be created seems unserious.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by solyin on Friday November 13, 2026 @10:43AM (#50485172)
As a random Internet commenter I can express an honest Ernest fervent hope that we'll solve cancer/etc and get fusion working on the next 5-10 years and there's no fraud. If I make that same claim while trying to get you to buy shares of my company at IPO that's a bit stickier. Companies making claims of wireless transmission of radio waves from NYC to London were sued for fraud, though one was ultimately successful at that. What material non-public information Dario has, we don't know. If he's sitting on information that makes it seem like it's not possible that is fraud. If he's sitting on tech that can simulate a human brain well enough to shorten the feedback loop in order to make that claim but doesn't want to make the claim publicly (GPU compute being semi-general purpose vs eg ASIC Bitcoin miners) that would be very exciting but if he's wildly guessing at the capabilities that AI could do in 5-10?years, that's another.
Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @10:49AM (#50485268)
My bet would be wild speculation, maybe based in some research they are doing.

I don't think they are holding anything back in revolutionary results or internal models, a week before the IPO.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by datsci_est_2015 on Friday November 13, 2026 @11:07AM (#50485562)
Credentials are just credentials. I've met plenty of cranks with impressive credentials. He doesn't even have to be dishonest or suffer from psychosis - you may just be putting far too much weight into his credentials, a mistake that is frequently made.
Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @11:14AM (#50485659)
How is that a mistake that is frequently made? The opposite is the case.

People are routinely claiming that as someone in tech, Amodei lacks credibility on biology and has no idea about science.

I'm yet to see someone claim his academic credentials validate his predictions.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by datsci_est_2015 on Friday November 13, 2026 @01:35PM (#50487788)
> How is that a mistake that is frequently made? The opposite is the case.

I wasn't talking about Amodei specifically, but in general: my take is that overweighting credentials is probably the number one mistake that is made in evaluating whether a complete stranger is qualified to do something or not, especially in positions of power.

If you gather 500 PhDs and put them in one room, and 500 individuals without post-secondary education in another, give them all a quiz, I'm sure that the former room will outperform the latter room on average. Pick one of those 500 PhDs at random and I can probably find a topic where they're completely out of their depth, and perhaps even arrogantly so: https://en.wikipedia.org/wiki/Nobel_disease